CACI Proprietary Information CACI International Inc Q1 FY23 Earnings Conference Call October 27, 2022 CACI Proprietary Information -- 1 of 18 -- 2 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call There are statements made herein that do not address historical facts and, therefore, could be interpreted to be forward- looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to risk factors that could cause actual results to be materially different from anticipated results. These risk factors include, but are not limited to, the following: our reliance on U.S. government contracts, which includes general risk around the government contract procurement process (such as bid protest, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities, such as for homeland security or to address global pandemics like COVID-19; legal, regulatory, and political change from successive presidential administrations that could result in economic uncertainty; changes in U.S. federal agencies, current agreements with other nations, foreign events, or any other events which may affect the global economy, including the impact of global pandemics like COVID-19; the results of government audits and reviews conducted by the Defense Contract Audit Agency, the Defense Contract Management Agency, or other governmental entities with cognizant oversight; competitive factors such as pricing pressures and/or competition to hire and retain employees (particularly those with security clearances); failure to achieve contract awards in connection with re-competes for present business and/or competition for new business; regional and national economic conditions in the United States and globally, including but not limited to: terrorist activities or war, changes in interest rates, currency fluctuations, significant fluctuations in the equity markets, and market speculation regarding our continued independence; our ability to meet contractual performance obligations, including technologically complex obligations dependent on factors not wholly within our control; limited access to certain facilities required for us to perform our work, including during a global pandemic like COVID-19; changes in tax law, the interpretation of associated rules and regulations, or any other events impacting our effective tax rate; changes in technology; the potential impact of the announcement or consummation of a proposed transaction and our ability to successfully integrate the operations of our recent and any future acquisitions; our ability to achieve the objectives of near term or long-term business plans; the effects of health epidemics, pandemics and similar outbreaks may have material adverse effects on our business, financial position, results of operations and/or cash flows; and other risks described in our Securities and Exchange Commission filings. Forward-looking Statements -- 2 of 18 -- 3 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call On Today’s Call John Mengucci President and Chief Executive Officer Thomas Mutryn Chief Financial Officer Jeffrey MacLauchlan Senior Vice President of Finance -- 3 of 18 -- 4 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Revenue +8%, organic growth +4% Adjusted EBITDA Margin 10.6%1 Strong free cash flow of $130 million1 Contract awards of $3.2 billion, >80% new business to CACI Q1 book-to-bill of 2.0x, trailing twelve months (TTM) book-to-bill 1.3x Q1 FY23 Financial Highlights 1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. -- 4 of 18 -- 5 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Market demand remains strong Continued bipartisan support for national security and modernization CR through December 16th but GFY23 budget seeing increases as it moves through Congress Higher spending in Defense, Intelligence, and Homeland Security Higher spending in key addressable areas including Digital Solutions, Enterprise IT, and C4ISR, Cyber, and Space Confident in our ability to drive long-term growth, margin expansion, robust cash flow, and shareholder value External Environment -- 5 of 18 -- 6 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Space Investing in photonics capabilities gained through LGS and SA Photonics acquisitions Focused on multi-year, technology-driven growth opportunities in Assured Positioning Navigation and Timing (APNT) and Laser Remote Sensing (or LiDAR) C4ISR CACI providing advanced, classified technology to the U.S. Space Force Investments in software-defined capabilities differentiating CACI in the market Enterprise IT Leveraging partnerships with commercial technology providers (e.g., AWS, ServiceNow) Won $5.7 billion Enterprise IT as-a-Service (EITaaS) Wave 1 from U.S. Air Force (approximately $2 billion included in Q1 FY23 contract awards and backlog) Technology enabling Expertise Leveraging technology investments to engage customers and differentiate CACI Expertise Investing Ahead of Need -- 6 of 18 -- 7 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Q1 Financial Summary $1,491 $1,606 $1,200 $1,300 $1,400 $1,500 $1,600 $1,700 Q1 FY22 Q1 FY23 Revenue (Ms) Organic revenue growth +4.3%, driven by new wins and on-contract growth Technology revenue +10.6% Adjusted EBITDA Margin of 10.6%1 GAAP EPS and Adjusted EPS up YoY on higher revenue and gross profit, and despite higher interest expense +7.7% 1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. $4.24 $4.36 $0.00 $1.00 $2.00 $3.00 $4.00 $5.00 $6.00 Q1 FY22 Q1 FY23 Adjusted EPS1 +2.8% $3.70 $3.76 $0.00 $1.00 $2.00 $3.00 $4.00 $5.00 Q1 FY22 Q1 FY23 EPS (GAAP) +1.6% -- 7 of 18 -- 8 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Strong Cash Flow $0 $100 $200 $300 $400 $500 $600 $700 $800 Cash Flow1 and CapEx (millions, TTM) Cash Flow from Operations excl. MARPA Capital Expenditures (CapEx) 1 $0.00 $5.00 $10.00 $15.00 $20.00 $25.00 $30.00 $35.00 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23E Free Cash Flow (FCF) per Share1,2 1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA). FY20 includes CARES Act payroll tax deferral benefit of ~$41 million. FY21 includes CARES Act payroll tax deferral benefit of ~$53 million and tax payment of ~$90 million related to certain tax elections. FY22 includes tax benefits of ~$190 million related to certain tax elections and repayment of payroll tax deferral of ~$47 million. FY23E includes estimated net tax payments of ~$25 million related to certain tax elections and repayment of payroll tax deferral of ~$47 million. See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. FY23E is based on guidance provided on October 26, 2022. Investors are reminded that actual results may differ from these estimates for reasons described in the Company’s Safe Harbor Statement and filings with the SEC. FY14 to FY19 FY15 to FY20 FY16 to FY21 FY17 to FY22 FY18 to FY23E 5-Year CAGR 10.6% 14.9% 19.2% 25.3% 9.5% 2 Assumes Section 174 of the Tax Cuts and Jobs Act of 2017 will be deferred, modified or repealed. CACI currently estimates that, if not deferred, modified or repealed, FY23 operating cash flow would be reduced by approximately $95 million. -- 8 of 18 -- 9 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Reaffirming FY23 Guidance FY23 Guidance Revenue (millions) $6,475 – $6,675 Adjusted Net Income1 (millions) $420 – $440 Adjusted Diluted EPS1 $17.65 – $18.49 Free Cash Flow1,2 (millions) At least $415 This guidance represents CACI views as of October 26, 2022. Investors are reminded that actual results may differ from these estimates for reasons described in the Company’s Safe Harbor Statement and filings with the SEC. Revenue growth of ~4.5% to ~7.5% Inorganic revenue of ~$180 million or ~3 points of growth Adjusted EBITDA Margin1 in the mid-to-high 10% range Interest expense of ~$75 million Diluted shares outstanding expected to be ~23.8 million Capital expenditures of ~$80 million 1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. 2 Assumes Section 174 of the Tax Cuts and Jobs Act of 2017 will be deferred, modified or repealed. CACI currently estimates that, if not deferred, modified or repealed, FY23 operating cash flow would be reduced by approximately $95 million. -- 9 of 18 -- 10 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Positive Forward Indicators 90% Existing Business STRONG Performance 5% Recompetes HIGH Win Rate 5% New Business QUALITY Pipeline Strong Q1 FY23 contract awards of $3.2 billion TTM Book-to-Bill of 1.3x Backlog of $24.9 billion, +4% YoY Pipeline of submitted bids: $10.8 billion >70% for new business to CACI Bids expected to be submitted in the next two quarters: $16.3 billion >90% for new business to CACI -- 10 of 18 -- 11 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call We delivered strong revenue growth, margins, and cash flow in Q1 Strong awards, growing backlog, and robust pipeline of opportunities Focused on long-term growth, margin expansion, robust cash flow, and free cash flow per share growth Successfully investing ahead of need to drive growth and differentiation Flexible and opportunistic capital deployment to deliver long-term shareholder value Talented, innovative, committed employees driving customer and CACI success Great Start to FY23 -- 11 of 18 -- 12 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Appendix -- 12 of 18 -- 13 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call FY23 Cash Flow Ms FY22 Cash from Operations excl. MARPA 1 $770 Method change in FY22 ($190) Method change delayed from FY22 $40 Method change impact in FY23 ($65) Working capital and other ($60) FY23 Cash from Operations excl. MARPA 1,2 $495 FY23 Capital expenditures $80 FY23 Free Cash Flow 1,2 $415 FY22 Cash from Operations excl. MARPA1 Method change in FY22 Method change delayed from FY22 Method change impact in FY23 Working capital and other FY23 Cash from Operations excl. MARPA1,2 1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. 2 Assumes Section 174 of the Tax Cuts and Jobs Act of 2017 will be deferred, modified or repealed. CACI currently estimates that, if not deferred, modified or repealed, FY23 operating cash flow would be reduced by approximately $95 million. This guidance represents CACI views as of October 26, 2022. Investors are reminded that actual results may differ from these estimates for reasons described in the Company’s Safe Harbor Statement and filings with the SEC. -- 13 of 18 -- 14 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Adjusted net income and Adjusted diluted EPS are non-GAAP performance measures. We define Adjusted net income and Adjusted diluted EPS as GAAP net income and GAAP diluted EPS, respectively, excluding intangible amortization expense and the related tax impact as we do not consider intangible amortization expense to be indicative of our core operating performance. We believe that these performance measures provide management and investors with useful information in assessing trends in our ongoing operating performance, provide greater visibility in understanding the long-term financial performance of the Company, and allow investors to more easily compare our results to results of our peers. The Company views Adjusted EBITDA and Adjusted EBITDA margin, both of which are defined as non-GAAP measures, as important indicators of performance, consistent with the manner in which management measures and forecasts the Company’s performance. Adjusted EBITDA is a commonly used non-GAAP measure when comparing our results with those of other companies. We define Adjusted EBITDA as GAAP net income plus net interest expense, income taxes, depreciation and amortization expense (including depreciation within direct costs), and earnout adjustments. We consider Adjusted EBITDA to be a useful metric for management and investors to evaluate and compare the ongoing operating performance of our business on a consistent basis across reporting periods, as it eliminates the effect of non-cash items such as depreciation of tangible assets, amortization of intangible assets primarily recognized in business combinations, as well as the effect of earnout gains and losses, which we do not believe are indicative of our core operating performance. Adjusted EBITDA margin is Adjusted EBITDA divided by revenue. A reconciliation of Adjusted EBITDA Margin to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to our inability to predict specific quantifications of the amounts that would be required to reconcile such measures. Consequently, any attempt to disclose such reconciliation would imply a degree of precision that could be confusing or misleading to investors. The Company defines Net cash provided by operating activities excluding MARPA, a non-GAAP measure, as net cash provided by operating activities calculated in accordance with GAAP, adjusted to exclude cash flows from CACI’s Master Accounts Receivable Purchase Agreement (MARPA) for the sale of certain designated eligible U.S. government receivables up to a maximum amount of $200.0 million. Free cash flow is a non-GAAP liquidity measure and may not be comparable to similarly titled measures used by other companies. The Company defines Free cash flow as Net cash provided by operating activities excluding MARPA, less payments for capital expenditures. The Company uses these non-GAAP measures to assess our ability to generate cash from our business operations and plan for future operating and capital actions. We believe these measures allow investors to more easily compare current period results to prior period results and to results of our peers. Free cash flow does not represent residual cash flows available for discretionary purposes and should not be used as a substitute for cash flow measures prepared in accordance with GAAP. These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. Definitions of Non-GAAP Measures -- 14 of 18 -- 15 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Reconciliation of Net Income to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands, except per share data) 9/30/2022 9/30/2021 % Change Net income, as reported 89,125 $ 88,109 $ 1.2% Intangible amortization expense 19,114 17,593 8.6% Tax effect of intangible amortization1 (4,950) (4,626) 7.0% Adjusted net income 103,289 $ 101,076 $ 2.2% 9/30/2022 9/30/2021 % Change Diluted EPS, as reported 3.76 $ 3.70 $ 1.6% Intangible amortization expense 0.81 0.74 9.5% Tax effect of intangible amortization1 (0.21) (0.20) 5.0% Adjusted diluted EPS 4.36 $ 4.24 $ 2.8% (in millions, except per share data) Low End High End Net income, as reported 364 $ --- 384 $ Intangible amortization expense 75 --- 75 Tax effect of intangible amortization1 (19) --- (19) Adjusted net income 420 $ --- 440 $ Low End High End Diluted EPS, as reported 15.29 $ --- 16.13 $ Intangible amortization expense 3.15 --- 3.15 Tax effect of intangible amortization1 (0.80) --- (0.80) Adjusted diluted EPS 17.65 $ --- 18.49 $ FY23 Guidance Range FY23 Guidance Range (1) Calculation uses an assumed full year statutory tax rate of 25.9% and 26.3% on non- GAAP tax deductible adjustments for September 30, 2022 and 2021, respectively. Three Months Ended Three Months Ended -- 15 of 18 -- 16 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Reconciliation of Net Income to Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands) 9/30/2022 9/30/2021 % Change Net income 89,125 $ 88,109 $ 1.2% Plus: Income taxes 27,485 28,522 -3.6% Interest income and expense, net 16,193 10,398 55.7% Depreciation and amortization expense, including amounts within direct costs 37,231 33,911 9.8% Adjusted EBITDA 170,034 $ 160,940 $ 5.7% (in thousands) 9/30/2022 9/30/2021 % Change Revenues, as reported 1,605,759 $ 1,490,898 $ 7.7% Adjusted EBITDA 170,034 160,940 5.7% Adjusted EBITDA margin 10.6% 10.8% Three Months Ended Three Months Ended -- 16 of 18 -- 17 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Reconciliation of Net Cash Provided by Operating Activities to Net Cash Provided by Operating Activities Excluding MARPA and to Free Cash Flow (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands) 9/30/2022 9/30/2021 Net cash provided by operating activities 144,843 $ 185,953 $ Cash used in (provided by) MARPA (1,904) (11,489) Net cash provided by operating activities excluding MARPA 142,939 174,464 Capital expenditures (12,771) (10,203) Free cash flow 130,168 $ 164,261 $ (in millions) FY23 Guidance Net cash provided by operating activities 495 $ Cash used in (provided by) MARPA - Net cash provided by operating activities excluding MARPA 495 Capital expenditures (80) Free cash flow 415 $ Three Months Ended -- 17 of 18 -- 18 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call Reconciliation of Net Cash Provided by Operating Activities to Net Cash Provided by Operating Activities Excluding MARPA, to Free Cash Flow, and to Free Cash Flow per share (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands, except per share data) 6/30/2014 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 (E) Net cash provided by operating activities 203,470 $ 226,862 $ 242,577 $ 281,250 $ 321,460 $ 555,297 $ 518,705 $ 592,215 $ 745,554 $ 495,000 $ Cash used in (provided by) MARPA - - - - - (192,527) (7,473) 17,973 24,242 - Net cash provided by operating activities excluding MARPA1 203,470 226,862 242,577 281,250 321,460 362,770 511,232 610,188 769,796 495,000 Capital expenditures (15,279) (17,444) (20,835) (43,268) (41,594) (47,902) (72,303) (73,129) (74,564) (80,000) Free cash flow 188,191 $ 209,418 $ 221,742 $ 237,982 $ 279,866 $ 314,868 $ 438,929 $ 537,059 $ 695,232 $ 415,000 $ Diluted weighted average shares outstanding 25,155 24,388 24,802 25,069 25,255 25,395 25,485 24,992 23,677 23,800 Free cash flow per share 7.48 $ 8.59 $ 8.94 $ 9.49 $ 11.08 $ 12.40 $ 17.22 $ 21.49 $ 29.36 $ 17.44 $ 5-Year CAGR 10.6% 14.9% 19.2% 25.3% 9.5% Twelve Months Ended 1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA). FY20 includes CARES Act payroll tax deferral benefit of ~$41 million. FY21 includes CARES Act payroll tax deferral benefit of ~$53 million and tax payment of ~$90 million due to certain tax elections. FY22 includes tax benefits of ~$190 million and repayment of payroll tax deferral of ~$47 million. FY23E includes estimated net tax payments of ~$25 million and repayment of payroll tax deferral of ~$47 million. Note: 6/30/2023 (E) reflects estimate for fiscal year 2023 based on financial guidance provided. 6/30/2023 (E) also assumes Section 174 of the Tax Cuts and Jobs Act of 2017 will be deferred, modified or repealed. CACI currently estimates that, if not deferred, modified or repealed, FY23 operating cash flow would be reduced by approximately $95 million. -- 18 of 18 --